Full Text View
Tabular View
No Study Results Posted
Related Studies
Dosing Study of Ara-C/EL625/Idarubicin in Refractory and Relapsed AML
This study has been completed.
Study NCT00074737   Information provided by Eleos, Inc.
First Received: December 19, 2003   Last Updated: March 20, 2008   History of Changes

No Study Results Posted for this Study
About Study Results Reporting
  Study Status: This study has been completed.
  Study Completion Date: May 2007
  Estimated Primary Completion Date: No date given